A243070 Stock Overview
Huons Co., Ltd. provides medical solutions for human health in Korea and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Huons Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩32,650.00 |
| 52 Week High | ₩39,700.00 |
| 52 Week Low | ₩27,600.00 |
| Beta | 0.69 |
| 1 Month Change | -0.31% |
| 3 Month Change | -3.26% |
| 1 Year Change | -16.50% |
| 3 Year Change | -22.54% |
| 5 Year Change | -48.32% |
| Change since IPO | -35.80% |
Recent News & Updates
Recent updates
Here's Why Huons (KOSDAQ:243070) Can Manage Its Debt Responsibly
Apr 20
We Think That There Are Issues Underlying Huons' (KOSDAQ:243070) Earnings
Mar 17Here's Why We Think Huons (KOSDAQ:243070) Is Well Worth Watching
Mar 12Is Huons Co., Ltd.'s (KOSDAQ:243070) Recent Performance Tethered To Its Attractive Financial Prospects?
Feb 21What Type Of Shareholders Own The Most Number of Huons Co., Ltd. (KOSDAQ:243070) Shares?
Feb 02Could Huons Co., Ltd. (KOSDAQ:243070) Have The Makings Of Another Dividend Aristocrat?
Jan 12Should You Buy Huons Co., Ltd. (KOSDAQ:243070) For Its Upcoming Dividend?
Dec 25
Update: Huons (KOSDAQ:243070) Stock Gained 28% In The Last Year
Dec 08Is Huons Co., Ltd.'s (KOSDAQ:243070) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Nov 18Shareholder Returns
| A243070 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -1.1% | -1.3% | -0.06% |
| 1Y | -16.5% | -13.0% | -4.0% |
Return vs Industry: A243070 underperformed the KR Pharmaceuticals industry which returned -12.1% over the past year.
Return vs Market: A243070 underperformed the KR Market which returned -2.8% over the past year.
Price Volatility
| A243070 volatility | |
|---|---|
| A243070 Average Weekly Movement | 4.3% |
| Pharmaceuticals Industry Average Movement | 4.3% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in KR Market | 12.3% |
| 10% least volatile stocks in KR Market | 2.9% |
Stable Share Price: A243070 is not significantly more volatile than the rest of KR stocks over the past 3 months, typically moving +/- 4% a week.
Volatility Over Time: A243070's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1965 | 819 | n/a | https://www.huons.com |
Huons Co., Ltd. provides medical solutions for human health in Korea and internationally. The company offers oral solid form drugs, including circulatory system, metabolic, antipyretic, analgesic, anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, and other chemotherapeutic products; and injection products, such as anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistamine, circulatory system, respiratory system, adrenocortical hormone, enzyme, mineral, solvent, calcium, hemostatic, antidote, antibiotic, metabolic, hyaluronic acid, well-being, anticoagulant, and other tissue cell system products. It also provides eye drop and bio products, as well as medical devices.
Huons Co., Ltd. Fundamentals Summary
| A243070 fundamental statistics | |
|---|---|
| Market Cap | ₩386.23b |
| Earnings (TTM) | ₩22.44b |
| Revenue (TTM) | ₩492.39b |
17.2x
P/E Ratio0.8x
P/S RatioIs A243070 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A243070 income statement (TTM) | |
|---|---|
| Revenue | ₩492.39b |
| Cost of Revenue | ₩224.56b |
| Gross Profit | ₩267.83b |
| Other Expenses | ₩245.39b |
| Earnings | ₩22.44b |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.90k |
| Gross Margin | 54.39% |
| Net Profit Margin | 4.56% |
| Debt/Equity Ratio | 33.3% |
How did A243070 perform over the long term?
See historical performance and comparison